Every new drug, vaccine and medical device must prove it is safe, stable and effective long before it reaches a patient, and the laboratories that generate that proof have become a critical checkpoint in drug development. According to Polaris Market Research, the global Healthcare Analytical Testing Services Market was valued at USD 6.38 billion in 2023 and is projected to reach USD 16.10 billion by 2032, growing at a CAGR of 10.8%.

The Shift: What's Actually Changing in Healthcare Analytical Testing

Analytical testing has moved well beyond routine quality checks. Providers now apply advanced analytical technologies to support disease identification, prognosis and personalized patient care, while pharmaceutical and biotech sponsors rely on the same services for drug development, efficacy evaluation and regulatory compliance in preclinical and clinical trials. AI-powered platforms are also turning biological testing data into refined preclinical results, shortening the path from molecule to candidate. Applications range from hospital and clinic diagnostics to specialized assays run by contract research organizations and academic institutions, all aimed at better patient outcomes. Those industry trends explain the double-digit market growth.

Healthcare Analytical Testing Services Market by the Numbers

Analysts estimate the market size at USD 7.06 billion in 2024, on the way to a much larger figure:

• 2023 Market Size: USD 6.38 billion
• 2032 Projected Size: USD 16.10 billion
• CAGR (2024–2032): 10.8%

👉 Want the full data behind this shift? Get a Free Sample Report

https://www.polarismarketresearch.com/industry-analysis/healthcare-analytical-testing-services-market 

Growth Drivers, Key Players and Market Segments to Watch

The expansion is being driven by faster technology adoption and a surge in clinical trials — every trial needs testing for drug safety, dosing, formulation, data integrity and quality control, and in July 2023 Broughton added Extractables and Leachables (E&L) testing to its analytical portfolio — with key players including Charles River Laboratories, Eurofins Scientific, LabCorp, and SGS shaping the competitive landscape across segments such as By Type (bioanalytical testing, physical characterization, method development and validation), By End-User, and By Region. Ongoing innovation by pharmaceutical, biopharmaceutical and medical device companies keeps generating new products that need testing.

Segment and Competitive Highlights

Bioanalytical testing, which covers drug quantification, metabolite identification and pharmacokinetic analysis for vaccines, small molecules and biologics, holds a considerable share. Pharmaceutical companies were a leading end-user group in 2023, while medical device companies are forecast to grow fastest as testing helps manufacturers manage product risk and meet regulatory standards. Other top companies include ICON plc, Intertek, Pace Analytical Services, PPD, Syneos Health and Toxikon. Deals are following demand: Alliance Pharma announced its acquisition of U.K.-based Drug Development Solutions in July 2025, and Merck invested €14 million in March 2024 to expand its Shanghai M Lab Collaboration Center. Cell-based assays are another significant segment, prized in biomedical research and drug-discovery screening because they measure cytotoxicity, biological activity and off-target interactions while reflecting physiological conditions more accurately than conventional biochemical assays. The type taxonomy is broad, also covering batch-release, raw material, stability and microbial testing and genomics services.

Challenges That Could Slow Growth

Cost is the main brake. Advanced instruments demand heavy capital investment, stringent regulation adds compliance expense, and skilled analysts are expensive to hire. That is why outsourcing decisions, and the choice of a provider with the right scale and expertise, carry real weight.

North America Leads Today, but Europe Is Catching Up Fast

North America holds the largest share and is expected to keep it, supported by demand from pharmaceutical, biopharmaceutical and medical device companies and by rising investment in analytical services. Europe is projected to be the fastest-growing region, as IoT-enabled devices, healthcare applications and a surge in digital records drive adoption of advanced analytics, delivering faster data-driven insights and helping lower healthcare costs. These services provide a reliable source of accuracy, quality and efficiency.

What This Means for Teams Tracking the Market Forecast 2032

For pharma sponsors, device makers and investors researching the Healthcare Analytical Testing Services market forecast 2032, the underlying report breaks down company positioning, segment-level forecasts, and regional opportunity through 2032 — useful context for any sourcing, partnership, or investment conversation happening right now. Because the field is fragmented and outsourcing continues to grow on cost considerations, the competitive analysis can help teams choose partners and see where specialized capabilities command a premium. Segment coverage runs from bioanalytical and stability testing to microbial and genomics services, with end-user views spanning pharmaceutical, medical device and biopharmaceutical firms, hospitals and clinics, and forensic labs.

The Road Ahead

As pipelines expand and regulators demand ever more rigorous data, analytical testing is set to become a strategic capability rather than a checkpoint. Look for more acquisitions, laboratory expansions and AI-enabled workflows, especially among providers that want to offer the full range from bioanalytical to stability and microbial testing. Government initiatives that encourage investment and innovation, along with companies entering new markets that need customized testing, should keep demand rising.

More Trending Latest Reports By Polaris Market Research:

jewelry-market

telehealth-market

hot-sauce-market

long-term-care-market

corrugated-plastic-sheets-a-sustainable-solution-for-modern-industry

cleanroom-technology-market

industrial-pumps-market

rising-demand-driving-additive-manufacturing

linseed-oil-market